CXCL8 and Miyoshi myopathy: In addition to the EGFR system, IL8, a cytokine well studied for its role in promoting tumor angiogenesis, cell motility, and invasion [19], has been described as an activator of bone destruction in metastatic and MM bone disease [20, 21].